AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find the latest Drugs in Development and Pipeline Prospector News of Bioiberica.

  • Webinars & Exhibitions

  • Chondroitin Sulfate

  • Glucosamine

  • Glucosamine Hydrochloride

  • Glucosamine Sulfate Potassium Chloride

  • Glucosamine Sulfate Sodium Chloride

  • Heparin Sodium

  • Thyroid

PharmaCompass
Bioiberica VB Read More
Bioiberica
Spain_new Flag
Country
Country
Spain
Address
Address
Av. Països Catalans 34, planta 2ª 08950 Esplugues de Llobregat, Barcelona
Telephone
Telephone
+34 934904908
Contact Info
Others

Maria Vilar
Strategic Marketing & Product Manager-Healthcare

Details:

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.


Lead Product(s): Hyaluronic Acid,Dermatan Sulfate,Collagen

Therapeutic Area: Dermatology Product Name: Dermial

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 25, 2022

Details:

By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.


Lead Product(s): Undenatured Type II Collagen

Therapeutic Area: Musculoskeletal Product Name: Collavant n2

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: ByHealth

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership March 11, 2022

Details:

Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.


Lead Product(s): Chondroitin Sulfate

Therapeutic Area: Musculoskeletal Product Name: CSbioactive

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 05, 2021

Details:

Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.


Lead Product(s): Hyaluronic Acid,Type II Collagen

Therapeutic Area: Musculoskeletal Product Name: Motilex HA

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Apsen

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership April 26, 2021

Details:

The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract rich in hyaluronic acid.


Lead Product(s): Undenatured Type II Collagen,Chondroitin Sulfate,Hyaluronic Acid

Therapeutic Area: Musculoskeletal Product Name: Mobilee

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 07, 2020

Details:

B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.


Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid

Therapeutic Area: Musculoskeletal Product Name: Colnatur Forte

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 15, 2020

Details:

Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.


Lead Product(s): Hyaluronic Acid,Type II Collagen,Polysaccharide

Therapeutic Area: Musculoskeletal Product Name: Meritene Mobilis

Highest Development Status: UndisclosedProduct Type: Small molecule

Recipient: Nestle Health Sciences SA

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership June 16, 2020

Details:

Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.


Lead Product(s): Chondroitin Sulfate,Glucosamine,Hyaluronic Acid

Therapeutic Area: Musculoskeletal Product Name: Condrovet

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Bayer AG

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement June 09, 2020

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY